Quantcast

REIT Bloodbath: Why Now Is The Time To Buy These 2 High-Yield REIT Blue Chips

Posted On October 31, 2016 4:08 pm
By:

REITs have had a rough few months, falling over 12%. Find out why two high-yield, grade A, medical REITs in particular are now undervalued, and more importantly why you should take this market opportunity to add them to your own portfolio.

Continue Reading Here

About author

Dividend Sensei

I'm an Army veteran and former energy dividend writer for The Motley Fool. I'm a proud co-founder of Wide Moat Research, Dividend Kings, and the Intelligent Dividend Investor. My work can be found on Seeking Alpha, Dividend Kings, iREIT, and the Intelligent Dividend Investor. My goal is to help all people learn how to harness the awesome power of dividend growth investing to achieve their financial dreams and enrich their lives. With 24 years of investing experience, I've learned what works and more importantly, what doesn't, when it comes to building long-term wealth and income streams and achieving long-term financial goals.

Related Articles

Leave a reply

Your email address will not be published. Required fields are marked *